The Relationship between 25 Hydroxy Vitamin D3 and Thyroid Antibodies with Thyroid Benign-Malign Neoplasms

Yildiz S., Ekinci O., Ucler R.

NIGERIAN JOURNAL OF CLINICAL PRACTICE, cilt.22, ss.1224-1228, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 22 Konu: 9
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4103/njcp.njcp_440_18
  • Sayfa Sayıları: ss.1224-1228


Objective: To study the relationship between vitamin D and thyroid antibodies with thyroid benign-malign neoplasms. Materials and Methods: The vitamin D vitamin and thyroid antibodies of 179 patients who underwent thyroidectomy for thyroid nodule were retrospectively reviewed. Results: The mean age of the patients was 44.97 +/- 14.139. Vitamin D levels were 14.473 +/- 4.9999 ng/ml in women and 19.584 +/- 6.1981 ng/ml in men and the mean was 15.016 +/- 5.3579 ng/ml. There was a significant relationship between sex and vitamin D level (P < 0, 05). Antithyroglobulin antibody (anti-TGB) had been detected in 95 patients and Antithyroid peroxidase antibody (anti TPO) in 58 patients. There was no significant relationship between vitamin D levels (P: 0, 65), anti-TPO positivity (P: 0, 86), and anti-TGB (P: 0, 12) with benign-malignant neoplasm of thyroid. There was no relationship between vitamin D and metastatic disease (P: 0, 30) as well. In addition, no association was found between malignancy and metastasis (P = 0.068, P = 0.14, P: 0, P = 0, respectively) with thyroid antibody positivity (anti TPO and/or anti TGB) in severe deficiency (<10 ng/ml) and deficiency (< 20 ng/ml) of vitamin D. Conclusion: Vitamin D deficiency or thyroid autoantibodies did not have any significant effect on thyroid malignancies or metastatic disease separately or together.